Affichage 1 à 8 des 8 essais cliniques
ESSAIS CLINIQUES
    No essai
    ClinicalTrials.gov ID
Phase Coordonnateur(rice)
(EN) A Phase 2/3 Multicenter, Open-label, 3-arm, 2-Stage Randomized Study of ASP2215 (Gilteritinib), Combination of ASP2215 Plus Azacitidine and Azacitidine Alone in the Treatment of Newly Diagnosed Acute Myeloid Leukemia With FLT3 Mutation in Patients Not Eligible for Intensive Induction Chemotherapy
    2215-CL-0201
    NCT02752035
     Actif en recrutement
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Phase II Lorena Iglesias
514-934-1934 poste 34907
(EN) Randomized, Open-label, 2-Arm, Multicenter, Phase 3 Study of Venetoclax and Azacitidine Versus Best Supportive Care as Maintenance Therapy for Patients With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
    M19-708 (VIALE-M)
    NCT04102020
     Actif en recrutement
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Banque des cellules leucémique du Québec
    banque cellules leucémique
     Actif en recrutement
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
Marie-Pierre Brochu
418-525-4444 poste 15768
Banque des cellules leucémique du Québec
    banque cellules leucémique
     Actif en recrutement
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
Linda Vallée
418-649-0252 poste 66602
(EN) A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) With ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD)
    CTTC 1901
    NCT04202835
     Actif en recrutement
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
Philippe Nadeau
418-649-0252 poste 63501
(EN) A Phase 1 Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
    LOXO-IDH-20001
    NCT04603001
     Actif en recrutement
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
(EN) A Phase II Multi-center, Single Arm, Safety and Efficacy Study of Sabatolimab in Combination With Azacitidine and Venetoclax for the Treatment of Acute Myeloid Leukemia (AML) in Adult Patients Unfit for Chemotherapy
    STIMULUS-AML1
    NCT04150029
     Actif en recrutement
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
Erika Thibault
514-340-8222
(EN) An Exploratory Phase 1/2 Open-Label Multi-Arm Trial to Evaluate the Safety and Efficacy of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
    CC-90009-AML-002
    NCT04336982
     Actif en recrutement
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
Julie Trinh Lu
514-252-3400 poste 3336